Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in Ann Arbor, MI
NPI: 1073606133Primary Practice Location
Michigan Head-Pain and Neurological Institute, PC
3120 Professional Dr, Ann Arbor, MI
Primary Employer
Michigan Head-Pain and Neurological Institute, PC
mhni.com
HQ Phone
Get D.O. James's Phone Numberphone_androidMobile
Get D.O. James's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 19 | 19 |
Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
Authors: William Mccall
Publication Date: 2010-10-21
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
Authors: Egilius Spierings, David Kudrow, Stewart Tepper, Peter Schmidt
Publication Date: 2017-10-13
Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial.
Authors: Cynthia Huffman
Publication Date: 2016-10-19
Lead Sponsor: Satsuma Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Dihydroergotamine
Lead Sponsor: Satsuma Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Placebos, DRUG: Dihydroergotamine
Lead Sponsor: Zosano Pharma Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: ZP-Zolmitriptan
